328 related articles for article (PubMed ID: 29925063)
1. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
2. SHP-1 in cell-cycle regulation.
López-Ruiz P; Rodriguez-Ubreva J; Cariaga AE; Cortes MA; Colás B
Anticancer Agents Med Chem; 2011 Jan; 11(1):89-98. PubMed ID: 21291405
[TBL] [Abstract][Full Text] [Related]
3. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
5. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
Sattler M; Salgia R; Shrikhande G; Verma S; Choi JL; Rohrschneider LR; Griffin JD
Oncogene; 1997 Nov; 15(19):2379-84. PubMed ID: 9393882
[TBL] [Abstract][Full Text] [Related]
6. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
7. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
Huang TT; Su JC; Liu CY; Shiau CW; Chen KF
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594363
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
Tibaldi E; Zonta F; Bordin L; Magrin E; Gringeri E; Cillo U; Idotta G; Pagano MA; Brunati AM
Biochim Biophys Acta; 2014 Feb; 1843(2):288-98. PubMed ID: 24140598
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
10. Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing.
Kakazu A; Sharma G; Bazan HE
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2927-35. PubMed ID: 18579758
[TBL] [Abstract][Full Text] [Related]
11. Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2.
Garg M; Wahid M; Khan F
Immunobiology; 2020 Jan; 225(1):151847. PubMed ID: 31561841
[TBL] [Abstract][Full Text] [Related]
12. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
13. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.
Lorenz U
Immunol Rev; 2009 Mar; 228(1):342-59. PubMed ID: 19290938
[TBL] [Abstract][Full Text] [Related]
14. Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.
Koncz G; Pecht I; Gergely J; Sármay G
Eur J Immunol; 1999 Jun; 29(6):1980-9. PubMed ID: 10382761
[TBL] [Abstract][Full Text] [Related]
15. Strategy for Leukemia Treatment Targeting SHP-1,2 and SHIP.
Hao F; Wang C; Sholy C; Cao M; Kang X
Front Cell Dev Biol; 2021; 9():730400. PubMed ID: 34490276
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor Binding Sites in the Protein Tyrosine Phosphatase SHP-2.
Zhang H; Gao Z; Meng C; Li X; Shi D
Mini Rev Med Chem; 2020; 20(11):1017-1030. PubMed ID: 32124695
[TBL] [Abstract][Full Text] [Related]
18. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
19. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
20. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
Burke TR; Zhang ZY
Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
